Regulatory Open Forum

 View Only
  • 1.  Patient Samples

    Posted 05-Mar-2020 07:46
    Hi Everyone,

    I am currently working on a project involving a device that will analyze patient urine samples. My question to the group is if the device validation testing utilizes patient urine would that be considered a clinical investigation per 21 CFR 812.3 (h)? Would your response change if the specimens were certified drug free urine samples? The results of the tests will not be reported to the patient. 

    Thank you.

    ------------------------------
    Michelle Hughes
    Senior Regulatory Affairs Consultant
    Jacksonville FL
    United States
    ------------------------------


  • 2.  RE: Patient Samples

    Posted 05-Mar-2020 16:02
    The samples are being used to determine the safety and/or effectiveness of the device, so they are clinical samples and you are performing a clinical investigation.

    ------------------------------
    Jeffrey Freedman
    Regulatory Affairs Specialist II
    Lowell MA
    United States
    ------------------------------



  • 3.  RE: Patient Samples

    Posted 06-Mar-2020 08:55
    Hello Michelle,

    It does not matter if the sample results are reported back to the patients, for IVD products if samples are taken from a patient, then it would be considered a clinical investigation.  With that said, there are some other methods can be utilised for IVD samples such as de-identified samples or leftover samples that could be used without performing a full clinical investigation.  The IVD world is a little different with clinical investigations, but if taking patient samples for any reason on non-approved/non-cleared devices, should still need a study in place.

    ------------------------------
    Richard Vincins RAC
    Vice President Global Regulatory Affairs
    ------------------------------